PAD4, a fundamental enzyme for histone citrullination and chromatin decondensation [75], has successfully been targeted by chloramidine, thus inhibiting NETs release in atherosclerotic murine models and alleviating atherosclerosis by decreasing lesion size [26,76]. The gene discussed is PADI4; the disease is atherosclerosis.